OSTX · OS Therapies Inc · Investor Relations
$1.26
-0.01 (-0.79%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$58.58M
Shares
46.13M
Volume · Oct 20
319.88K
Avg daily vol (3M)
581.43K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-09 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-04-30 | OST-HER2 Pharmacodynamic Response Biomarker Conference Call | Conference |
Source: https://ir.ostherapies.com/